Stelara® (ustekinumab) – Expanded indication
October 13, 2017 – Janssen announced the FDA approval of Stelara (ustekinumab) for adolescent patients (12 years or older) with moderate to severe plaque psoriasis, who are candidates for phototherapy or systemic therapy.
Download PDF
